QTNTQ — Quotient Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.16m
- $252.30m
- $38.51m
Annual income statement for Quotient, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K/A | 10-K/A | 10-K/A | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 24.7 | 29.1 | 32.7 | 43.4 | 38.5 |
| Cost of Revenue | |||||
| Gross Profit | 14.3 | 11.9 | 14.9 | 23.3 | 14.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 94.7 | 108 | 113 | 126 | 143 |
| Operating Profit | -70 | -79.2 | -80.4 | -82.7 | -105 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -83 | -106 | -105 | -110 | -124 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -82.3 | -106 | -105 | -111 | -125 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -82.3 | -106 | -105 | -111 | -125 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -82.3 | -106 | -105 | -111 | -125 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -80.6 | -77.6 | -58.7 | -47.8 | -48.9 |